Episode Summary
Executive Summary: The episode examines how the pandemic disrupted sleep routines, increased insomnia and anxious dreams, and boosted use of sleep aids. Dr. Jennifer Martin explains that chronic insomnia is best treated with cognitive behavioral therapy for insomnia (CBTI), not over-the-counter aids or repeated prescriptions, and that restoring routines and boundaries will help many people recover while others may need clinical support.
Main Topics: Pandemic-related sleep disruption (Priority: 5/5): Stress, uncertainty, and routine changes during COVID broadly worsened sleep, with many people sleeping more or less than desired and healthcare/essential workers hit especially hard. Health consequences of short sleep (Priority: 5/5): Sleeping fewer than seven hours regularly affects mood, memory, stress coping, metabolism, obesity risk, and cardiovascular health; treating sleep problems can improve these outcomes. Chronic insomnia vs. sleep hygiene (Priority: 5/5): Sleep hygiene is useful for prevention, but chronic insomnia is a disorder that often requires CBTI rather than just better habits or environmental tweaks. Over-the-counter sleep aids and melatonin (Priority: 4/5): Popular OTC products are widely used but are not recommended by major guidelines, may have side effects, and often appear effective mainly because of placebo effects and reduced trying. Anxious dreams and nightmares (Priority: 3/5): Stressful events, including the pandemic, can produce distressing dreams during REM sleep; most will fade as routines normalize, but persistent nightmares may require treatment. Access to evidence-based treatment (Priority: 4/5): Evidence-based CBTI can be delivered in person, online, app-based, or through trained non-psychologists; apps such as Insomnia Coach and CBTI Coach were highlighted. Long-term lessons from the pandemic (Priority: 4/5): The pandemic may teach people to protect sleep time, respect individual sleep needs, and maintain boundaries between work and home life, especially for remote workers.
Key Arguments: Pandemic stress and disrupted routines directly worsened sleep for most people, not just a small subset. Insufficient sleep has wide-ranging physical and psychological effects, but treating sleep disorders can improve health markers and functioning. Most adults need at least seven hours of sleep regularly to stay healthy and well. Chronic insomnia should be defined clinically by poor sleep at least three times a week for at least three months. CBTI is the first-line treatment for chronic insomnia and should generally be offered before medications. Sleep hygiene alone rarely fixes chronic insomnia; it is better understood as prevention than treatment. OTC sleep aids and melatonin are not recommended by major clinical guidelines and may work mostly through placebo and reduced sleep effort. Patients often prefer behavioral treatment over medication, but many do not know these options exist or how to access them. Evidence-based CBTI can be delivered through multiple formats, including apps and supervised non-psychologist providers. The pandemic may leave a subset of people with persistent sleep problems that require formal treatment even after normal routines return.
Data Points: People sleeping more or less than desired since the pandemic began: 2 out of 3 - APA Stress in America survey cited at the start of the interview Reporting less sleep than wanted: 35% - APA survey result Reporting more sleep than wanted: 31% - APA survey result Recommended regular sleep duration for most adults: at least 7 hours - Dr. Martin's general guideline for healthy sleep Duration threshold for insomnia disorder: at least 3 months - Poor sleep persisting long enough to qualify as chronic insomnia Frequency threshold for insomnia disorder: at least 3 times a week - Clinical definition of insomnia disorder Long-sleep epidemiology association: 9 hours or more a night - Studies noting shorter survival among self-reported long sleepers Pre-pandemic insomnia prevalence in women: 20% - Dr. Martin cites estimated burden before COVID Pre-pandemic insomnia prevalence in men: 10% - Dr. Martin cites estimated burden before COVID Increase in OTC sleep aid and melatonin sales: tripled or doubled - Sales rose sharply during the pandemic compared with the prior year Teen sleep increase during pandemic: at least 1 hour per night - Her children reportedly slept more during remote-learning periods Ideal sleep need for daughter: closer to 9 hours/night - Personal anecdote illustrating that many people may underestimate needs Ideal sleep need for son: 9.5 hours/night - Personal anecdote illustrating individual sleep requirements
Pivotal Quotes: "you can't try your way to sleep. So the best way to fall asleep is to stop trying." — Dr. Jennifer Martin: Explaining the core behavioral insight behind CBTI and why effortful trying can worsen insomnia "Sleep hygiene on its own does not work for the vast majority of people who have chronic insomnia problems." — Dr. Jennifer Martin: Clarifying why basic sleep tips are usually insufficient for chronic insomnia "CBTI should be offered to most patients in most circumstances, and prescription sleep aids should be offered to some patients some of the time." — Dr. Jennifer Martin: Summarizing guideline-based treatment priorities for insomnia
Implications: Listeners should protect sleep routines, seek help if insomnia lasts months, and prioritize CBTI over unproven sleep aids. The episode suggests sleep medicine and psychology should expand access to behavioral treatment, including app-based care.